Gainers
- ARS Pharmaceuticals SPRY shares increased by 79.4% to $8.11 during Friday's regular session. ARS Pharmaceuticals's stock is trading at a volume of 50.1 million shares as of 13:30 EST. This is 16117.0% of its average full-day volume over the last 100 days. The company's market cap stands at $766.1 million.
- AirSculpt Technologies AIRS stock rose 40.49% to $6.87. Trading volume for AirSculpt Technologies's stock is 1.0 million as of 13:30 EST. This is 432.4% of its average full-day volume over the last 100 days. The company's market cap stands at $389.6 million. The company's, Q1 earnings came out today.
- Dermata Therapeutics DRMA shares moved upwards by 32.12% to $2.55. Dermata Therapeutics's stock is trading at a volume of 36.1 million shares as of 13:30 EST. This is 1443.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.1 million. The company's, Q1 earnings came out yesterday.
- Apyx Medical APYX stock moved upwards by 22.09% to $5.47. The current volume of 1.1 million shares is 747.1% of Apyx Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $189.2 million. As per the press release, Q1 earnings came out yesterday.
- VYNE Therapeutics VYNE stock moved upwards by 17.83% to $7.19. The current volume of 107.2K shares is 14.9% of VYNE Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $23.4 million. As per the news, the Q1 earnings report came out yesterday.
- Meihua Intl Medical Techs MHUA stock increased by 14.37% to $3.5. Meihua Intl Medical Techs's stock is trading at a volume of 1.3 million shares as of 13:30 EST. This is 1976.1% of its average full-day volume over the last 100 days. The company's market cap stands at $83.7 million.
Losers
- Assure Hldgs IONM stock fell 38.4% to $1.19 during Friday's regular session. Trading volume for Assure Hldgs's stock is 2.8 million as of 13:30 EST. This is 723.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 million. The company's, Q1 earnings came out 2 days ago.
- Heron Therapeutics HRTX shares fell 37.9% to $1.39. The current volume of 10.8 million shares is 531.7% of Heron Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $165.2 million. As per the press release, Q1 earnings came out yesterday.
- Impel Pharmaceuticals IMPL shares fell 33.61% to $1.51. Trading volume for Impel Pharmaceuticals's stock is 109.6K as of 13:30 EST. This is 227.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $35.9 million. As per the press release, Q1 earnings came out today.
- ViewRay VRAY shares fell 28.01% to $0.6. Trading volume for this security as of 13:30 EST is 5.8 million, which is 265.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $109.3 million. As per the news, the Q1 earnings report came out 2 days ago.
- Xenetic Biosciences XBIO shares decreased by 27.53% to $0.29. Trading volume for Xenetic Biosciences's stock is 443.0K as of 13:30 EST. This is 1347.5% of its average full-day volume over the last 100 days. The company's market cap stands at $4.3 million. As per the news, the Q1 earnings report came out yesterday.
- Aquestive Therapeutics AQST stock decreased by 26.91% to $1.82. Trading volume for this security as of 13:30 EST is 2.0 million, which is 497.5% of its average full-day volume over the last 100 days. The company's market cap stands at $101.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in